The Pennant Group, Inc. (PNTG) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2025)
PNTG's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
PNTG Revenue Analysis (2017–2025)
As of March 1, 2026, The Pennant Group, Inc. (PNTG) generated trailing twelve-month (TTM) revenue of $947.7 million, reflecting explosive growth of +53.2% year-over-year. The most recent quarter (Q4 2025) recorded $289.3 million in revenue, up 26.3% sequentially.
Looking at the longer-term picture, PNTG's 5-year compound annual growth rate (CAGR) stands at +19.4%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $947.7 million in 2025, representing a new all-time high.
Revenue diversification analysis shows PNTG's business is primarily driven by Home Health And Hospice Services Segment (77%), and Senior Living Services Segment (23%). With over half of revenue concentrated in Home Health And Hospice Services Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ENSG (+17.5% YoY), EHC (+11.1% YoY), and BKD (+7.3% YoY), PNTG has outperformed the peer group in terms of revenue growth. Compare PNTG vs ENSG →
Peer Comparison
Compare PNTG's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PNTGCurrent | $948M | +53.2% | +19.4% | 5.5% | |
| ENSG | $5.1B | +17.5% | +16.1% | 8.4% | |
| EHC | $5.9B | +11.1% | +10.7% | 12.8% | |
| BKD | $3.2B | +7.3% | +1.1% | 2.7% | |
| NHC | $1.5B | +22.1% | +8.4% | 8.7% | |
| SEM | $5.5B | -35.0% | -0.3% | 0.0% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $947.7M | +36.3% | $0 | - | $51.9M | 5.5% |
| 2024 | $695.2M | +27.6% | $93.8M | 13.5% | $38.1M | 5.5% |
| 2023 | $544.9M | +15.1% | $67.0M | 12.3% | $25.2M | 4.6% |
| 2022 | $473.2M | +7.6% | $58.6M | 12.4% | $12.7M | 2.7% |
| 2021 | $439.7M | +12.5% | $48.6M | 11.1% | $4.7M | 1.1% |
| 2020 | $391.0M | +15.5% | $54.9M | 14.0% | $18.9M | 4.8% |
| 2019 | $338.5M | +18.3% | $44.6M | 13.2% | $5.7M | 1.7% |
| 2018 | $286.1M | +14.0% | $42.4M | 14.8% | $20.6M | 7.2% |
| 2017 | $251.0M | - | $32.4M | 12.9% | $15.4M | 6.1% |
See PNTG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PNTG Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare PNTG vs AGIO
See how PNTG stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is PNTG's revenue growth accelerating or slowing?
PNTG revenue is accelerating at +53.2% year-over-year, exceeding the 5-year CAGR of +19.4%. TTM revenue reached $948M. Growth momentum has increased versus prior periods.
What is PNTG's long-term revenue growth rate?
The Pennant Group, Inc.'s 5-year revenue CAGR of +19.4% reflects the sustained expansion pattern. Current YoY growth of +53.2% is above this long-term average.
How is PNTG's revenue distributed by segment?
PNTG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.